At the Theoretical Chemical Biology and Protein Modelling group of the Technical University of Munich 1 Ph.D. position is available, starting September 2010, in the context a DFG funded collaboration project in the area of Protein Engineering and Design. The goal of the project is to extend the group software DynaCell, which was successfully introduced [...]
At the Department of Materials Science and Engineering, a PhD position is offered within crystallization of solar cell silicon. NTNU and SINTEF have, over the last few years, built a strong research group and dedicated laboratories on the production, crystallization and characterization of silicon for solar cells in order to do research together with the [...]
Job Description: Applications are invited for two funded Ph.D. positions in the Knowledge and Data Engineering Research Group (KDEG), Discipline of Intelligent Systems, School of Computer Science and Statistics at Trinity College Dublin (TCD). KDEG enjoys a world-class reputation in the areas of adaptation research, intelligent systems and knowledge driven information systems. Successful candidates will [...]
Job Description: In order to fully understand the causes and consequences of international movements in Europe, researchers and policy makers need to overcome the limitations of the various data sources, including inconsistencies in availability, definitions and quality. At present, there has been little research on bringing together multiple sources of data to provide better pictures [...]
The Distributed Object Programming Lab (DOPLab), at the University of Lausanne, is opening a PhD position in computer science, specialization in mobile distributed systems, coupled to an assistant position at 100%. The DOPLab is part of the Information Systems Institute (ISI) of HEC Lausanne. Work location: University of Lausanne, Switzerland
Acute lymphoblastic leukemia (ALL) is the most common malignancy in childhood. ALL relapse remains one of the most frequent diagnoses in pediatric oncology. These patients desperately need new treatment options. Combination therapy with new agents that target regulators of programmed cell death constitutes a promising approach to improve treatment of resistant disease. Our own data [...]